Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Vivos Therapeutics Inc. (VVOS) Message Board

Sleep Apnea More Prevalent Among Children, Can Imp

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 51
(Total Views: 201)
Posted On: 10/06/2021 4:50:48 PM
Avatar
Posted By: NetworkNewsWire
Sleep Apnea More Prevalent Among Children, Can Impact Grades

Nemours Children’s Health director of preventive cardiology Dr. Carissa Baker-Smith stated in a recent interview that disrupted and poor sleep in children could be linked to difficulty focusing in the daytime. This, she added, could negatively affect their performance in school.

Sleep apnea is a sleeping disorder known to cause serious health problems. When untreated, sleep apnea causes an individual’s breathing to stop repeatedly while they’re sleeping. This, in turn, causes loud snoring and fatigue in the daytime, despite having a full night’s sleep.

The main types of sleep apnea are:

Central sleep apnea

This occurs when an individual’s brain doesn’t send the correct signals to the muscles that control breathing, thereby triggering intermittent breathing.

Obstructive sleep apnea

This is the most common type of apnea and occurs when an individual’s throat muscles relax and air can’t flow freely when the person is asleep.

Complex sleep apnea syndrome

This occurs when an individual suffers from both central sleep apnea and obstructive sleep apnea.The disorder, which is common in teenagers and kids, may be linked to changes in heart structure and high blood pressure.

The American Heart Association notes that obstructive sleep apnea affects between 30%–60% of obese teenagers and up to 6% of all children. These disruptions in sleep have also been associated with abnormal lipids and insulin resistance and can also elevate blood pressure, which may be harmful to the children’s cardiovascular health when they’re older.

Teachers and parents are advised to remain alert and observe for any symptoms of obstructive sleep apnea in their children as this will allow for earlier diagnosis and treatment.

The most common symptoms of sleep apnea include:

Frequent urination in the nighttime
Night sweats
Mood disturbances
Cognitive impairment, which includes irritability and forgetfulness
Sore throat or dry mouth when an individual awakens
Awakening suddenly with a sensation of choking or gasping
Restlessness when one is sleeping
Daytime fatigue or sleepiness
Morning headaches
The risk factors for obstructive sleep apnea in children include:

Enlarged tonsils and adenoids
Nasal congestion
Excess weight or obesity
Family history
A narrowed airway
Medical conditions such as type 2 diabetes and congestive heart failure
Parents or guardians who notice any of these symptoms should talk to their child’s pediatrician, who may refer the child to an otolaryngologist if their tonsils are enlarged. Resetting children’s bedtimes so that they can get the recommended hours of sleep every night may also be helpful.

Baker-Smith recommends that children aged 13 to 18 should sleep for 8 to 10 hours while those aged 6 to 12 should sleep for 9 to 12 hours. Additionally, kids aged between 2 to 5 should get between 10 to 13 hours of sleep while those under 2 years should sleep for 11 to 14 hours.

If sleep apnea is positively diagnosed, remedies made by companies such as Vivos Therapeutics Inc. (NASDAQ: VVOS) can be of great help in addressing this condition which has the potential to trigger several other complications.

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics Inc. (NASDAQ: VVOS) are available in the company’s newsroom at http://ibn.fm/VVOS

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




Vivos Therapeutics Inc. (VVOS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us